Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | ImCheck Therapeutics Biotechnology Research, biotech, deeptech | Other 26 May 2024 | | |
 | Protéines France Food and Beverage Manufacturing, agritech | Other 2 Oct 2022 | | |
 | Angels Santé Venture Capital and Private Equity Principals | Other 28 Apr 2021 12 Jun 2023 | | |
 | NaoX Technologies Wellness and Fitness Services, healthtech, biotech, deeptech | Other 28 Feb 2022 | | |
 | Andera Partners Venture Capital and Private Equity Principals | Other 30 Jun 2024 | | |
 | secpho Non-profit Organizations, deeptech | Other 2 Jan 2023 | | |
 | DNA Script Biotechnology Research, biotech, deeptech | Other 26 May 2024 | | |
 | Gilde Healthcare Financial Services | Other 22 Mar 2021 26 Apr 2023 | | |
 | Wellington Partners Venture Capital and Private Equity Principals | Other 30 Jun 2024 | | |
 | Fountain Healthcare Partners Venture Capital and Private Equity Principals | Other 30 Jun 2022 | | |